PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+3.14%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(+38%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
27.16%
Top 10 Holdings %
Top 10 Hldgs %
99.86%
Holding
13
New
1
Increased
1
Reduced
4
Closed
2
Top Buys
| 1 |
Pulmatrix
PULM
|
$1 |
Top Sells
| 1 |
Cardlytics
CDLX
|
$25.8M |
| 2 |
Fate Therapeutics
FATE
|
$5.18M |
| 3 |
TTOO
T2 Biosystems, Inc
TTOO
|
$3.09M |
| 4 |
KALA BIO
KALA
|
$2.51M |
| 5 |
TRVN
Trevena, Inc.
TRVN
|
$2.12M |
Sector Composition
| 1 | Communication Services | 28.72% |
| 2 | Healthcare | 22.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cardlytics
CDLX
$54.3M
| $50.6M | 28.72% | 1,508,065 -769,277 | -34% | -$25.8M |
|
|
2
Fate Therapeutics
FATE
$120M
| $17.7M | 10.06% | 1,139,783 -333,403 | -23% | -$5.18M |
|
3
Neuronetics
STIM
$220M
| $6.09M | 3.46% | 732,583 -9,706 | -1% | -$80.7K |
|
4
Cartesian Therapeutics
RNAC
$261M
| $4.85M | 2.76% | 2,773,479 | – | – |
|
|
5
KALA BIO
KALA
$78.8M
| $4.56M | 2.59% | 1,197,032 -660,550 | -36% | -$2.51M |
|
6
X4 Pharmaceuticals
XFOR
$84.2M
| $3.96M | 2.25% | 311,492 | – | – |
|
|
GNCA
7
DELISTED
Genocea Biosciences, Inc.
GNCA
| $714K | 0.41% | 246,078 | – | – |
|
|
ATYR
8
aTyr Pharma
ATYR
$527M
| $457K | 0.26% | 130,571 | – | – |
|
|
9
Pulmatrix
PULM
$18M
| $294K | 0.17% | 359,439 +1 | +0% | +$1 |
|
10
Dare Bioscience
DARE
$27.2M
| $254K | 0.14% | 326,243 | – | – |
|
|
TRVN
11
DELISTED
Trevena, Inc.
TRVN
| – | – | -2,053,540 | Closed | -$2.12M |
|
|
TTOO
12
DELISTED
T2 Biosystems, Inc
TTOO
| – | – | -1,841,924 | Closed | -$3.09M |
|